Allyl(â-ketoiminato)palladium(II) Complexes
Organometallics, Vol. 18, No. 5, 1999 865
of palladium. In all cases analyses are corrected for relative
sensitivities of each element.
Calcd for C15H19NOPd: C, 43.89; H, 6.28; N, 5.12. Found: C,
44.27; H, 6.21; N, 5.28.
Com p lex 4, [P d (η3-CH2CMeCH2)(Mea ca c)]. MS (FAB,
107Pd): m/z 273 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
5.31-5.21 (m, 1H), 4.74 (s, 1H), 3.70-3.60 (m, 1H), 3.45 (s,
3H), 3.00 (d, 1H, J HH ) 6.7 Hz), 2.46 (d, 1H, J HH ) 11.5 Hz),
1.94 (s, 3H), 1.90 (s, 3H), 1.29 (d, 3H, J HH ) 6.3 Hz). 13C NMR
(75 MHz, CDCl3, 293 K): δ 177.1, 165.4, 114.3, 97.7, 75.6, 49.3,
49.1, 26.9, 21.2, 16.1. Anal. Calcd for C10H17NOPd: C, 43.89;
H, 6.26; N, 5.12. Found: C, 44.20; H, 6.12; N, 5.22.
Complex 5, [P d (η3-CH2CMeCH2)(Moa ca c)]. MS (FAB,
107Pd): m/z 317 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
5.31-5.21 (m, 1H), 4.93 (s, 1H), 3.96-3.87 (m, 1H), 3.85-3.76
(m, 1H), 3.71-3.61 (m, 1H), 3.50 (t, 2H, J HH ) 6.6 Hz), 3.29
(s, 3H), 2.93 (d, 1H, J HH ) 6.5 Hz), 2.44 (d, 1H, J HH ) 11.6
Hz), 1.93 (s, 3H), 1.91 (s, 3H), 1.31 (d, 3H, J HH ) 6.2 Hz). 13C
NMR (75 MHz, CDCl3, 293 K): δ 177.8, 165.3, 133.7, 98.1,
76.2, 73.5, 59.3, 59.0, 48.8, 27.1, 21.2, 16.0. Anal. Calcd for
Allylpalladium complexes with the empirical formula
[(allyl)Pd(µ-Cl)]2 were prepared according to literature proce-
dures.5 Ketoimines were prepared from the direct condensation
of acetylacetone and amines at room temperature,6 or from
reaction of hexafluoroacetylacetone and amines using mont-
morillonite K10 as a catalyst.7 Abbreviations used for the
â-ketoiminate ligands are as follows: Mehfac ) CF3COCHCCF3-
NMe, Buhfac ) CF3COCHCCF3NnBu, Mohfac ) CF3COCHC-
CF3NCH2CH2OMe, Alhfac ) CF3COCHCCF3NCH2CHdCH2,
Phacac ) MeCOCHCMeNPh, Meacac ) MeCOCHCMeNMe,
Moacac ) MeCOCHCMeNCH2CH2OMe, Alacac ) MeCOCHC-
MeNCH2CHdCH2. Two typical synthetic procedures for the
preparation of â-ketoiminato Pd complexes are described
below, together with spectral and analytical data for the
compounds prepared. Due to thermal instability or physical
state, some compounds did not give satisfactory elemental
analyses. 1H NMR spectra for these complexes (2, 6, 8-11,
13, 14) have been deposited in the Supporting Information.
[P d (η3-CH2CMeCH2)(P h a ca c)] (1). A mixture of distilled
water (40 mL), NaOH (250 mg), and PhacacH (175 mg, 1.00
mmol) was stirred at 45 °C for 30 min to give a homogeneous
solution, which was then added to a suspension of [Pd(η3-CH2-
CMeCH2)(µ-Cl)]2 (217 mg, 0.55 mmol) in diethyl ether (20 mL).
The mixture was stirred for 10 min, and the ether layer was
separated, washed with distilled water (3 × 10 mL) and dried
over sodium sulfate; then the solvent was evaporated to give
the product [Pd(η3-CH2CMeCH2)(Phacac)] as a yellow solid
(yield, 289 mg, 86%). Single crystals of 1 suitable for an X-ray
diffraction study were obtained from recrystallization in
saturated acetone solution at room temperature.
[P d (η3-CH2CMeCH2)(Meh fa c)] (15). A mixture of diethyl
ether (30 mL), NaOMe (200 mg), and MehfacH (450 mg, 2.04
mmol) was stirred at room temperature for 30 min to give a
homogeneous solution, which was then added to a mixture of
[Pd(η3-CH2CMeCH2)(µ-Cl)]2 (400 mg, 1.02 mmol) and NaOH
(250 mg) in water (50 mL). The mixture was vigorously stirred
for 10 min; the ether layer was separated, washed with
distilled water (3 × 10 mL), and dried over sodium sulfate.
Then the solvent was evaporated to give the product [Pd(η3-
CH2CMeCH2)(Mehfac)] as a yellow solid (yield, 740 mg, 95%).
Sp ectr oscop ic Da ta for â-Ketoim in a to Com p lexes.
Com p lex 1, [P d (η3-CH2CMeCH2)(P h a ca c)]. MS (FAB,
107Pd): m/z 335 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
7.24 (t, 2H, J HH ) 7.5 Hz), 7.00 (t, 1H, J HH ) 7.5 Hz), 6.88 (br,
1H), 4.97 (s, 1H), 3.52 (d, 1H, J HH ) 2.8 Hz), 2.73 (s, 1H), 2.34
(s, 1H), 2.03 (s, 3H), 1.98 (s, 3H), 1.92 (d, 1H, J HH ) 2.8 Hz),
1.64 (s, 3H). 13C NMR (75 MHz, CDCl3, 293 K): δ 178.7, 163.9,
156.9, 130.5, 128.5 (2C), 123.7 (2C), 122.8, 97.3, 58.8, 57.1, 27.1,
23.3, 22.9. Anal. Calcd for C15H19NOPd: C, 53.67; H, 5.70; N,
4.17. Found: C, 53.19; H, 5.65; N, 4.30.
C
12H21NO2Pd: C, 45.37; H, 6.66; N, 4.41. Found: C, 45.80; H,
6.56; N, 4.60.
Com p lex 6, [P d (η3-CH2CMeCH2)(Ala ca c)]: MS (FAB,
107Pd): m/z 299 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
5.91-5.79 (m, 1H), 5.14-5.07 (m, 2H), 4.80 (s, 1H), 4.36-4.33
(m, 2H), 3.56 (d, 1H, J HH ) 2.8 Hz), 2.86 (d, 1H, J HH ) 2.8
Hz), 2.82 (s, 1H), 2.60 (s, 1H), 2.08 (s, 3H), 1.96 (s, 3H), 1.88
(s, 3H). 13C NMR (75 MHz, CDCl3, 293 K): δ 176.8, 165.5,
135.6, 130.6, 114.6, 98.0, 62.0, 58.4, 54.5, 26.7, 23.2, 21.0.
Com p lex 7, [P d (η3-CH2CMeCHMe)(Mea ca c)]: MS (FAB,
107Pd): m/z 287 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
5.06 (dd, 1H, J HH ) 12.0, 7.1 Hz), 4.72 (s, 1H), 3.45 (s, 3H),
3.00 (d, 1H, J HH ) 7.1 Hz), 2.64 (d, 1H, J HH ) 12.0 Hz), 1.89
(s, 3H), 1.84 (s, 3H), 1.40 (s, 3H), 1.20 (s, 3H). 13C NMR (75
MHz, CDCl3, 293 K): δ 177.8, 165.6, 108.5, 97.5, 88.7, 49.1,
46.7, 27.2, 25.0, 21.0, 20.9. Anal. Calcd for C11H19NOPd: C,
45.93; H, 6.66; N, 4.87. Found: C, 46.66; H, 6.46; N, 4.95.
Com p lex 8, [P d (η3-CH2CH CMe2)(Moa ca c)]. MS (FAB,
107Pd): m/z 331 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
5.09 (dd, 1H, J HH ) 12.0 Hz, 7.2 Hz), 4.74 (s, 1H), 3.97-3.80
(m, 2H), 3.54 (t, 2H, J HH ) 3 Hz), 3.33 (s, 3H), 2.96 (dd, 1H,
J HH ) 7.3 Hz, 1.3 Hz), 2.63 (dd, 1H, J HH ) 12.0, 1.3 Hz), 1.93
(s, 3H), 1.92 (s, 3H), 1.44 (s, 3H), 1.22 (s, 3H). 13C NMR (75
MHz, CDCl3, 293 K): δ 178.6, 165.5, 108.1, 98.1, 86.6, 73.5,
59.3, 59.1, 46.2, 27.4, 25.1, 21.1, 21.0.
Com plex 9, [P d(η3-CH2CMeCMeCH2OMe)(Moacac)]: MS
(FAB, 107Pd): m/z 375 (M+). 1H NMR (300 MHz, CDCl3, 293
K): δ 4.74 (s, 1H), 3.87 (t, 2H, J HH ) 6.3 Hz), 3.64 (d, 1H, J HH
) 10.6 Hz), 3.51 (t, 2H, J HH ) 6.3 Hz), 3.32 (s, 3H), 3.16 (s,
3H), 3.10 (d, 1H, J HH ) 10.6 Hz), 2.96 (d, 1H, J HH ) 1.1 Hz),
2.86 (d, 1H, J HH ) 1.1 Hz), 2.11 (s, 3H), 1.92 (s, 3H), 1.91 (s,
3H), 1.40 (s, 3H). 13C NMR (75 MHz, CDCl3, 293 K): δ 178.3,
165.4, 123.5, 98.0, 80.7, 73.4, 73.0, 59.1 (2C), 57.3, 51.6, 27.2,
21.2 (2C), 17.1.
Com p lex 2, [P d (η3-CH2CHCH2)(Mea ca c)]. 1H NMR (300
MHz, CDCl3, 293 K): δ 5.67-5.54 (m, 1H), 4.80 (s, 1H), 3.78
(d, 1H, J HH ) 6.9 Hz), 3.49 (s, 3H), 3.22 (d, 1H, J HH ) 6.6 Hz),
3.01 (d, 1H, J HH ) 12.5 Hz), 2.71 (d, 1H, J HH ) 11.7 Hz), 2.00
(s, 3H), 1.95 (s, 3H). 13C NMR (75 MHz, CDCl3, 293 K): δ
175.8, 165.4, 115.1, 97.8, 60.0, 53.2, 49.1, 26.3, 21.5.
Com p lex 3, [P d (η3-CH2CHCHMe)(Mea ca c)]. MS (FAB,
107Pd): m/z 273 (M+). 1H NMR (300 MHz, CDCl3, 293 K): δ
4.78 (s, 1H), 3.54 (d, 1H, J HH ) 2.6 Hz), 3.45 (s, 3H), 2.96 (d,
1H, J HH ) 2.6 Hz), 2.84 (s, 1H), 2.62 (s, 1H), 2.10 (s, 3H), 1.91
(s, 3H), 1.86 (s, 3H). 13C NMR (75 MHz, CDCl3, 293 K): δ
176.1, 165.4, 130.7, 97.7, 58.5, 53.5, 49.1, 26.5, 23.4, 21.5. Anal.
Com p lex 10, [P d (η3-CH2CMeCMeCH2OMe)(Meh fa c)].
MS (FAB, 107Pd): m/z 439 (M+). 1H NMR (300 MHz, CDCl3,
293 K): δ 5.60 (s, 1H), 3.74 (d, 3H, J HH ) 2.0 Hz), 3.62 (d, 1H,
J HH ) 10.7 Hz), 3.32 (s, 1H), 3.18 (s, 3H), 3.12 (d, 1H, J HH
)
10.7 Hz), 3.11 (s, 1H), 2.17 (s, 3H), 1.39 (s, 3H). 13C NMR (75
MHz, CDCl3, 293 K): δ 166.1 (q, CO, J CF ) 32 Hz), 155.6 (q,
CN, J CF ) 26 Hz), 126.9, 120.1 (q, CF3, J CF ) 282 Hz), 120.0
(q, CF3, J CF ) 286 Hz), 87.5, 84.9, 73.7, 58.3, 55.1, 50.7, 21.6,
18.2.
Com p lex 11, [P d (η3-CH2CMeCMeCH2OMe)(Moh fa c)].
1H NMR (300 MHz, CDCl3, 293 K): δ 5.61 (s, 1H), 4.10-4.03
(m, 2H, J HH ) 6.9 Hz), 3.65-3.57 (m, 3H), 3.38 (d, 1H, J HH
)
10.6 Hz), 3.35 (s, 3H), 3.19 (s, 3H), 3.13 (s, 1H), 3.10 (d, 1H,
J HH ) 10.6 Hz), 2.19 (s, 3H), 1.40 (s, 3H). 13C NMR (75 MHz,
CDCl3, 293 K): δ 166.4 (q, CO, J CF ) 32 Hz), 156.1 (q, CN,
J CF ) 26 Hz), 126.6, 120.0 (q, CF3, J CF ) 286 Hz), 119.9 (q,
CF3, J CF ) 279 Hz), 87.6, 85.2, 74.6, 73.6, 60.8, 59.8, 58.4, 55.6,
21.5, 18.2.
(5) (a) Robinson, S. D.; Shaw, B. L. J . Chem. Soc. 1963, 4806. (b)
Sakakibara, M.; Takahashi, Y.; Sakai, S.; Ishii, Y. J . Chem. Soc., Chem.
Commun. 1969, 396. (c) Akermark, B.; Hansson, S.; Krakenberger, B.;
Vitagliano, A.; Zetterberg, K. Organometallics 1984, 3, 679.
(6) Greenhill, J . V. J . Chem. Soc. Rev. 1977, 6, 277.
(7) Braibante, M. E. F.; Braibante, H. S.; Missio, L.; Andricopulo,
A. Synthesis 1994, 898.